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Background/aim: Human alveolar epithelial cells play a critical role in the pathogenesis of lung diseases. The objective of this study is to
determine the contribution of beraprost sodium, a prostaglandin I2 (PGI2) analogue, to inflammatory and oxidative events in response
to lipopolysaccharide (LPS) in airway epithelial cells.
Materials and methods: Human pulmonary alveolar epithelial cells (A549) were pretreated with 10 µM beraprost sodium 30 min before
stimulation with 1 µg/mL LPS for 24 h. The cellular viability assessments were evaluated by quantitative MTT test. Catalase activity
and glutathione and lipid peroxidation levels were determined using spectrophotometric techniques. mRNA expression analyses were
performed by real-time qRT-PCR.
Results: The endotoxin induced a dose-dependent increase in proliferation of the cells, which was suppressed by the beraprost sodium
treatment. LPS increased the expressions of TNF-α and IL-1β genes by 8- and 2.5-fold, respectively. It also induced lipid peroxidation
and depleted cellular antioxidant capacity. Pretreatments of the cells with beraprost sodium significantly reversed the inflammation and
suppressed oxidative stress.
Conclusion: These findings suggest that beraprost sodium will provide a pivotal molecular basis for the design of new therapeutic
strategies to cure endotoxin-induced lung injury, although additional comprehensive studies are still required.
Key words: Lung, epithelial cells, beraprost sodium, lipopolysaccharide, inflammation, oxidative stress

1. Introduction
Acute lung injury (ALI) is associated with significant
morbidity and mortality in human patients (1). ALI is
regarded as an increased inflammatory response that
might cause morphological and functional damage to the
respiratory membrane. Lung alveolar epithelial cells, which
are characteristically the major cells with endothelial cells
challenged by pathogenic bacteria (2,3), participate in the
beginning and the development of ALI. Alveolar epithelial
cells may also contribute to inflammatory events in ALI as
they are an important source of cytokines (e.g., TNF-α, IL1β, IL-6) under inflammatory conditions (4,5). Infection,
and particularly gram-negative bacterial sepsis, is an
important etiological factor for ALI (6), and endotoxin
lipopolysaccharide (LPS) is an essential component of
gram-negative bacterial cell walls (7). In the human lung,
LPS results in the activation of a number of inflammatory
pathways and therefore is often used as a valuable model
to study potential processes associated with gram-negative
sepsis (8,9). The present treatment for ALI comprises
* Correspondence: suaterdogan@trakya.edu.tr
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supportive and antiinflammatory treatments. Nevertheless,
the consequences of these actions are not always adequate.
Cyclic adenosine monophosphate (cAMP) is an
intracellular second messenger that mediates the effects of
many hormones, β-adrenergic agonists, and prostaglandins
(PGs) (8,10,11). Elevated cAMP concentrations in many
cells types may suppress inflammation by inhibiting
cytokine secretion and oxidative stress (12–14).
Prostaglandin I2 (PGI2), a major product of arachidonic
acid, causes a significant increase in the cAMP production
of many cell types (13,15). PGI2 analogues can attenuate
inflammation via suppressing TNF-α, IL-1β, and IL-6
production in lungs, human monocytes, and endothelial
cells (11,13,16,17). Beraprost sodium, a chemically stable
PGI2 analogue, has been shown to possess a similar
pharmacological profile to PGI2 (18). Beraprost mimics
the biological properties of PGI2, such as activation of
adenylate cyclase and increasing intracellular cAMP
concentrations, through activation of the PGI2 receptor
(19). Owing to its chemical characteristics, beraprost is
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a more stable molecule with a longer life and a higher
affinity to PGI2 receptors than natural PGI2 (20).
The A549 human alveolar epithelial cell line, which
has many of the features of alveolar type II epithelial
cells, is frequently used as a surrogate for human alveolar
epithelium because of the limitations of primary cells. LPS
is frequently used to initiate inflammation in A549 cells to
simulate the pathogen-associated molecular pattern of ALI
in vitro. The PGI2 receptor is expressed in alveolar epithelial
cells (21), but the effects of beraprost on inflammation and
oxidative stress in these cells have not been documented.
We applied LPS to stimulate A549 cells and investigated
the effects of beraprost on the cell proliferation, expression
of selected proinflammatory cytokines, lipid peroxidation,
and antioxidative status.
2. Materials and methods
2.1. Cell culture
Adenocarcinomic human pulmonary alveolar basal
epithelial cells (A549) were kindly provided by Dr J Mazella
(CNRS, Valbonne, France). The cells were maintained in
DMEM (low glucose, Sigma) supplemented with 10% fetal
bovine serum and penicillin/streptomycin at 100 IU/mL
and 100 mg/mL, respectively, and incubated at 37 °C in
a humidified atmosphere of 5% CO2/95% air. Cells were
digested with 0.25% trypsin and subcultured at 70% to
80% confluence.
2.2. Cell viability assay
The epithelial cells were cultured overnight at a density
of 10 × 104/well or 5 × 104/well in a sterile 12-well or 24well plate, respectively (Costar, Corning Inc., USA). The
viability of the cells was analyzed based on the activity of
mitochondrial dehydrogenase to reduce dimethylthiazoldiphenyltetrazolium bromide (MTT) (Fluka) to formazan.
Briefly, A549 cells were seeded in 12-well plates and treated
with DMSO or different concentrations of beraprost
(1–100 µM) for 3–48 h (data not shown), and then 1 mg/
mL MTT was added to each well with incubation for an
additional 2 h in culture. The resulting formazan product
was dissolved in acid-isopropanol, and the absorbance was
measured at a wavelength of 570 nm.
2.3. Concentration and time response for LPS and
beraprost
For the dose-response, cells were stimulated with 0.1–5
µg/mL of E. coli LPS serotype 0111:B4 (Sigma) for 24 h. In
some experiments, the medium also contained beraprost
(10 µM), in which case cells were pretreated for 30 min
with this agent. This concentration of beraprost has
been shown to be able to suppress LPS-induced cytokine
expressions in vitro (11,16,22).
2.4. LPS stimulation of A549 cells
A549 cells were incubated in 12- or 24-well culture
plates, and LPS (E. coli 0111:B4, Sigma) was added in the

logarithmic phase. The final concentration of LPS was
determined by MTT assays in which 0.1, 1.0, and 5.0 µg/
mL were evaluated successively (Figure 1A). There were
no significant differences in the rate of cell growth at 3 h
after LPS treatment when all the concentrations were used
(data not shown). However, 1 µg/mL LPS significantly
induced cell proliferation rate (P < 0.05) at 24 h incubation.
Therefore, 1 µg/mL was the concentration of LPS used in
all subsequent experiments. Cells were collected from
wells 24 h after adding LPS.
2.5. Determination of intracellular reduced glutathione
(GSH) concentration
At the end of the incubations, cells were washed and lysed
with ice-cold homogenization buffer (1% Triton X-100
(Merck), 50 mM HEPES (pH 7.2), 10 mM EDTA, 100
mM NaH2PO4-2H2O) with a complete protease inhibitor
mixture (aprotinin, phenylmethylsulfonyl fluoride,
leupeptin, sodium fluoride) (Sigma, Germany). The
detergent-insoluble proteins and tissue fragments were
discarded by centrifugation at 12,000 × g for 10 min at
4 °C, and the cytosolic fraction was reserved for further
analyses. The protein concentrations of the cell extracts
were measured by the Bradford reagent using bovine
serum albumin as a standard. GSH concentrations in
cellular homogenates were determined according to the
method developed by Sedlak and Lindsay (23). GSH is
reacted with 5,5-dithiobis-2-nitrobenzoic acid, yielding
the formation of a product that has a maximal absorbance
at 410 nm. The data are given as µmol/mg protein.
2.6. Catalase activity analysis
Catalase activity was assessed using the method of Luck
(24). Three milliliters of H2O2 phosphate buffer (12.5
mM H2O2 in 67.0 mM phosphate buffer (pH 7.0)) was
pipetted directly into the cuvette. An appropriate amount
of homogenate was added to the buffered solution. The
contents were mixed and the decrease in absorbance was
measured at 240 nm for 3 min. The activity was shown
as k/mg protein in homogenates, where k is the degree
constant of a first-order reaction.
2.7. Malondialdehyde analysis
Lipid peroxidation status was evaluated by measuring the
concentration of malondialdehyde (MDA) in the cellular
homogenates of the samples (25). The homogenate was
precipitated with trichloroacetic acid and reacted with
thiobarbituric acid in a boiling water bath for 30 min. Tubes
were then immediately cooled in ice-cold water, and 4 mL
of n-butanol was added. After centrifugation at 3000 rpm
for 10 min, the absorbance intensity of the upper phase was
measured by a spectrophotometer (Shimadzu UV-1208,
Japan) at 535 nm. Values were compared with a series of
standard solutions (1,1,3,3-tetramethoxypropane). Results
were expressed as µmol per mg protein.
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3. Results
3.1. Effect of beraprost sodium on cell growth
The effect of beraprost sodium on cell proliferation
stimulated by LPS was investigated in A549 cells. The
cells were incubated with various concentrations of
LPS (0.1, 1, and 5 µg/mL) for 24-h periods (Figure 1A).
LPS stimulated the proliferation of the cells in a dosedependent manner, as measured by MTT assay. The
highest increase in metabolic activity was induced by 1 µg/
mL LPS stimulation. In response to 1 µg/mL LPS from E.
coli 0111:B4, MTT activity was increased to 156% after 24 h
of stimulation (P < 0.001) (Figure 1A). On the other hand,
the cells pretreated with beraprost (10 µM) significantly
inhibited (P < 0.001) cellular proliferation stimulated by
LPS to the level of control (Figure 1B).
3.2. Beraprost sodium protects alveolar epithelial cells
against LPS-induced oxidative stress
In A549 cells, we measured the lipid peroxidation levels
(MDA) as a marker of oxidative stress (Table). The levels
of this marker were compared between the groups that
underwent 24 h of beraprost sodium treatment for LPS
exposure and the control group (nonexposed group). A
significantly increased MDA level was observed in the
LPS-exposed group (P < 0.001) in comparison to the
control group, suggesting LPS-induced oxidative damage.
However, beraprost significantly (P < 0.001) reduced lipid
peroxidation induced by LPS.
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2.8. qRT-PCR analysis
Real-time PCR was implemented in a qPCR system (Stratagene
Mx 3005P, USA). Total RNA from A549 cells was extracted using
TRIzol reagent (Sigma, USA). RNA was reverse-transcribed
with a commercial kit (Fermentas, Lithuania). The primer
sets obtained from Thermo Electron Corporation (Germany)
were TNF-α (sense 5’-CAGAGGGAAGAGTTCCCCAG-3’,
anti-sense 5’-CCTTGGTCTGGTAGGAGACG-3’) and IL1β (sense 5’-GCAAGCGCTTCAGGCAGGCGGCG-3’, antisense 5’-GGTCATTCTCCTGGAAGGTCTGTGGGC-3’).
The amount of RNA was normalized to β-actin
amplification
in
a
separate
reaction
(sense
5’-CATCGTCACCAACTGGGACGAC-3’,
anti-sense
5’-CGTGGCCATCTCTTGCTCGAAG-3’). Quantifying the
relative changes in mRNA expressions of target mRNA was
considered using the 2ΔΔCt procedure, where ΔΔCt = (Ctgene
– Ctβ-actin)treated – (Ctgene studied – Ctβ-actin)control. The rise in
studied
fluorescent signal related to the exponential increase of PCR
yields was detected by the laser detector.
2.9. Statistical analysis
One-way analysis of variance (ANOVA) and post hoc
Duncan tests were carried out on the data to examine the
differences among groups using SPSS for Windows v. 9.0.
The results are presented as average ± standard error (SE).
P < 0.05 was considered significant.
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Figure 1. Dose-dependent induction of A549 proliferation by
lipopolysaccharide (LPS) (A) and the effect of beraprost sodium
(BPS) on stimulation (B). A549 cells were incubated in the absence
or presence of various concentrations of LPS from E. coli 0111:B4
and/or 10 µM beraprost sodium for 24 h. LPS induced a dosedependent increase in proliferation of A549 cells as quantified by
MTT test (A). BPS did decrease cell proliferation induced by 1.0
µM LPS (B). *: P < 0.001 vs. control/zero. Values are expressed as
the mean ± SE from at least 3 different experiments.

Reduced glutathione (GSH), a major nonprotein thiol
involved in many aspects of cellular metabolism and
regulation, plays an important role in cellular antioxidant
defense systems by scavenging free radicals and other
reactive oxygen species (ROS), removing hydrogen and
lipid peroxides, and precluding oxidation of biomolecules.
LPS-induced oxidative stress caused significant depletion
of GSH levels in the cells (P < 0.001) (Table). However,
beraprost-treated cells demonstrated higher GSH levels
than the untreated control cells (P < 0.05). Similar
to this result, beraprost elevated LPS-decreased GSH
concentration to the control level (P < 0.001).
We measured the antioxidant catalase enzyme activity
that may reflect intracellular defenses. Catalase is a crucial
enzyme in cellular antioxidant defense systems, as it has
critical roles in the elimination of H2O2 in living organisms.
Catalase converts H2O2 to water and molecular oxygen.
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Table. Effects of beraprost sodium (BPS) on oxidant-antioxidant parameters of LPS-induced human pulmonary alveolar
epithelial cells (A549).
Control

LPS

BPS

+ BPS

MDA levels (µmol/mg protein)

0.08 ± 0.003

0.29 ± 0.007*

0.07 ± 0.003

0.14 ± 0.004¥

GSH levels (µmol/mg protein)

1.27 ± 0.02

0.64 ± 0.01*

1.65 ± 0.03#

1.30 ± 0.02¥

Catalase activity (k/mg protein)

0.47 ± 0.09

0.15 ± 0.03*

1.44 ± 0.05##

0.62 ± 0.05¥

Malondialdehyde (MDA) and reduced glutathione (GSH) levels and catalase activity were measured in the cellular
homogenates in the absence or presence of 1 µg/mL LPS and/or 10 µM beraprost sodium for 24 h. *: P < 0.001 vs. control,
#
: P < 0.05 vs. control, ##: P < 0.001 vs. control, ¥: P < 0.001 vs. LPS. Values are expressed as the means ± SE from at least 3
different experiments.

4. Discussion
We used the A549 cell line as representative alveolar
epithelial cells that have been implicated in the
pathogenesis of sepsis-induced ALI (27,28). Epithelial
cells produce various immune effectors such as cytokines
and antimicrobial peptides in response to inflammatory
stimuli (28). Although most PGs have proinflammatory
actions, PGI2 (11) and PGE2 (29) are reported as having
antiinflammatory effects that are both potent and
context-dependent. PGI2 analogues can regulate cytokine
expression of T cells, monocytes, and macrophages via
IP receptor (11). PGI2 analogues play a role in airway
remodeling induced by repeated allergen challenge in
mice (30). Though the PGI2 receptor is expressed in
alveolar epithelial cells (21), the role of PGI2 analogues
against endotoxin-induced inflammation and oxidative
events remains to be revealed in these cells.
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Inadequate elimination of ROS results in oxidative stress
that may cause severe metabolic malfunctions and can
damage biological macromolecules. In the present study,
LPS significantly (P < 0.001) reduced catalase activity
in the cells (Table). Similar to the protection of the cells
from lipid peroxidation, beraprost elevated LPS-inhibited
catalase activity (P < 0.001).
3.3. Effect of beraprost sodium on proinflammatory
cytokine production by A549 cells stimulated with LPS
A549 cells in culture are known to express genes of
proinflammatory cytokines such as TNF-α and IL-1β
(26), which trigger inflammatory responses. To determine
the effect of beraprost on LPS-induced proinflammatory
cytokine gene expressions, qRT-PCR was conducted in
A549 cells at 24 h. We found that LPS (1 µg/mL) increased
production of TNF-α and IL-1β expressions by 8- and 2.5fold, respectively (P < 0.001). In contrast, 10 µM beraprost
pretreatment 30 min before LPS significantly reversed
these cytokine mRNA expressions (Figures 2A and 2B) (P
< 0.001).
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Figure 2. Proinflammatory cytokine expression of A549
epithelial cells in the presence of lipopolysaccharide (LPS) and/
or beraprost sodium (BPS, +BPS). A549 cells were cultured in
standard medium without LPS (control) and in the presence of
1 µg/mL LPS from E. coli 0111:B4 and 10 µM BPS. Relative gene
expression of proinflammatory cytokines IL-1β and TNF-α in
A549 cells in standard medium (control) and in standard medium
in the presence of LPS and BPS. The total mRNA was isolated
from the cells after 24 h, and real-time qRT-PCR was performed
using specific primers. Gene expression was calibrated to β-actin
as a housekeeping gene (n = 3). *: P < 0.001 vs. control, **: P<
0.001 vs. LPS.
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Our findings suggest that LPS from E. coli 0111:B4
can promote A549 cell proliferation and induce
oxidative stress and inflammation, which is consistent
with previous studies (6,31–33). Our data suggest that
endotoxin is an applicable and powerful promoter of
tumor cell proliferation. The escalation in metabolic
activity was previously noted after 24 h of LPS treatment
and A549 cells are well known to correspond to cellular
proliferation (32). The obtained results indicate that
beraprost treatment significantly reverse LPS-induced
cell proliferation. Though the intracellular cAMP level
was not measured in this study, it has already been shown
that cAMP concentration is induced by PGI2 analogues,
including beraprost, as well as different cAMP-elevating
agents (18,34–36). These agents have antiproliferative
and antioxidant effects, as demonstrated by in vivo and
in vitro studies. cAMP activates protein kinase A to
initiate multiple phosphorylation reactions and thus
regulates various functions within cells. Beraprost is
able to elevate intracellular cAMP concentration and
promotes peroxisome proliferator-activated receptor
δ (PPARδ) activity (37,38). PPARδ modulates target
gene expressions in response to ligand activation after
heterodimerization with the receptor and the binding to
peroxisome proliferator-responsive elements of target
genes (38). Therefore, PPARδ-mediated modulation
of gene transcription by PGI2 may form the basis for its
novel role as a regulator of gene expression. Thus, our data
suggest that beraprost could be beneficial to control cell
proliferation during endotoxin exposure in lungs.
Recent studies have reported that LPS enables the
production of ROS, leading to lipid peroxidation in lungs
and resulting in lung damage (39–41). Therefore we
measured the antioxidant GSH levels and catalase enzyme
activities, as well as lipid peroxidation levels that may
reflect intracellular defenses. GSH, a major nonprotein
thiol involved in many aspects of cellular metabolism and
regulation, has an important role in the cellular antioxidant
protection system by scavenging free radicals and
preventing oxidation of biomolecules (40). LPS-induced
oxidative stress can lead to significant depletion of GSH
level in the cells (42). Our study indicated that exposing
A549 cells to LPS depletes GSH levels and catalase activity,

and results in lipid peroxidation. Pretreating the cells with
10 µM beraprost for 30 min before LPS exposure resulted
in a significant decrease in lipid peroxidation and elevated
GSH levels and catalase activity. This finding corroborates
the ideas of Brown et al. and Mishima et al. (12,19), who
suggested that beraprost or cAMP-elevating agents protect
renal tubular cells against cisplatin-induced oxidative
injury by obliterating ROS and the subsequent inhibition
of TNF-α synthesis through a blockade of p38 MAPK
activation. Based on the present study and previous data,
it can be suggested that supporting the antioxidant system
with beraprost sodium helps to ameliorate LPS-caused
oxidative stress.
LPS-induced ALI is characterized by alveolar epithelial
permeability, inflammatory mediator release, and a
neutrophilic inflammatory response (13,40). TNF-α and
IL-1β are suggested as important early mediators of ALI
under pathophysiological conditions (43). In relation
with its antiinflammatory activity, beraprost has been
demonstrated to inhibit TNF-α and IL-1β release by
downregulating NF-κB or p38 MAPK activation signaling
via intracellular cAMP elevation (11,13,17,19,44,45).
In this experiment, we found that pretreatment with
beraprost (10 µM) effectively decreased the concentrations
of TNF-α and IL-1β compared with the LPS group. These
results indicated that the protective effect of beraprost on
LPS-induced ALI could also be attributed to the inhibition
of proinflammatory cytokine release.
Beraprost sodium is an orally active prostacyclin
analogue used clinically for the treatment of peripheral
arterial disease and pulmonary arterial hypertension.
However, its inhibitory effect on the formation of
inflammation and oxidative stress has not been revealed
in pulmonary alveolar epithelial cells. The results obtained
from this study show that beraprost sodium could provide
a pivotal molecular basis for the design of new therapeutic
strategies to cure endotoxin-induced lung injury, although
further comprehensive studies are still required.
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